Peanut (Ara h 3) IgE Test · Blood

If you or your child has had an uncertain reaction to peanuts, or a standard peanut allergy test came back positive but the clinical picture is murky, this test answers a more specific question: is your immune system reacting to one of the actual storage proteins inside the peanut, or just to something that looks like one?

Peanut Ara h 3 IgE (immunoglobulin E to peanut allergen component 3) is one of the molecular pieces of a peanut allergy workup. It zooms in on a single protein inside the peanut and asks whether your body has built antibodies specifically against it. Used alongside other component tests, it helps separate true food allergy from harmless sensitization.

What This Test Actually Measures

Peanuts contain several different proteins. Ara h 3 is an 11S globulin, one of the main storage proteins that peanut seeds use to hold the building blocks they need to grow. The blood test measures IgE antibodies, the class of antibody your immune system makes when it has decided to treat something as a threat, that are aimed specifically at Ara h 3.

A positive result means your immune system is sensitized to this particular peanut protein. Sensitization is the immunological setup for an allergic reaction, but it is not the same as a clinical allergy. Many people who are sensitized to peanut components can eat peanuts without reacting. That gap between sensitization and true allergy is the entire reason component testing exists.

Why Ara h 3 Matters in Peanut Allergy

Component-resolved diagnostics, the broader approach this test belongs to, break peanut allergy down into reactions against individual proteins. Ara h 3 sits in the same family as Ara h 1, the two other major storage proteins implicated in serious peanut reactions. People who react clinically to peanut tend to make antibodies against these storage proteins; people who are merely sensitized through pollen cross-reactivity usually do not.

In a large US cohort of more than 12,000 peanut-sensitized patients, sensitization to storage proteins including Ara h 1, Ara h 2, and Ara h 3 was particularly common in young children. In infants and toddlers with early-onset peanut allergy, Ara h 3 IgE was detected in 43% at diagnosis. Higher Ara h 3 IgE and a broader peanut antibody response also track with stronger activation of the allergy cells (basophils and mast cells) that drive real reactions.

How Ara h 3 Compares to Ara h 2

Across nearly every cohort studied, Ara h 2 is the single most informative peanut component. Ara h 3 is supportive but secondary. A meta-analysis found that at the standard positivity threshold, Ara h 3 picked up about 39 out of 100 true peanut allergy cases (sensitivity 39%) but correctly cleared roughly 88 out of 100 non-allergic people (specificity 88%). Ara h 2, by comparison, caught about 83 out of 100 true cases with similar specificity.

Sources: Nilsson et al. 2019 meta-analysis; Hemmings et al. 2020; Ebisawa et al. 2012.

What this means for you: Ara h 3 IgE rarely changes the diagnostic story on its own. It earns its place by adding confidence when other components are also positive, or by flagging the small group of people sensitized to storage proteins without elevated Ara h 2. If you are testing your peanut risk, Ara h 3 is most useful as part of a panel, not as a standalone number.

Reaction Severity and Risk Patterns

When Ara h 3 IgE is part of a broader antibody response that also includes Ara h 1 and Ara h 2, the picture often points to clinical peanut allergy with the potential for systemic reactions, including anaphylaxis. Co-sensitization across multiple storage proteins has been linked with more severe reactions, though Ara h 2 and Ara h 6 carry most of the predictive weight for severity.

Functional studies add nuance. Higher Ara h 3 IgE relative to total IgE, and a more diverse peanut antibody response that includes Ara h 3, correlate with stronger activation of the immune cells that release histamine during a reaction. The quality and breadth of the antibody response, not just the amount of any single component, seem to shape how the body actually behaves on exposure.

Tracking Your Levels Over Time

A single Ara h 3 reading is a snapshot. The more useful question is how the number moves over months and years, because peanut allergy can resolve naturally in some children, and antibody profiles shift with treatment. In a longitudinal cohort, falling peanut and Ara h 2 specific IgE over time was associated with the natural resolution of peanut allergy in childhood, with about one-third of infant peanut allergy resolved by age 10.

If you are managing a diagnosed peanut allergy or undergoing oral immunotherapy, get a baseline, retest at 6 to 12 months to confirm the trajectory, and then at least annually. If the numbers are dropping alongside expanding food tolerance, that is a meaningful signal. If they are climbing or static while symptoms persist, the case for continued strict avoidance and emergency planning is reinforced.

What to Do With an Unexpected Result

A positive Ara h 3 IgE in someone who has never reacted to peanuts is common and not, on its own, a diagnosis of peanut allergy. The right next move depends on the rest of the picture. If Ara h 2 is also positive, the probability of true clinical allergy rises sharply, and an allergist visit is warranted before any peanut exposure trial. If Ara h 2 is negative and only Ara h 3 is elevated, the result is harder to interpret and usually needs specialist input, sometimes including an oral food challenge under medical supervision.

Companion tests that sharpen the read include Ara h 2, Ara h 6, Ara h 1, total IgE, and whole peanut extract IgE. In specialist centers, a basophil activation test can refine risk further, particularly when standard tests are equivocal. Never use this test to decide on your own whether peanuts are safe to eat after a previous reaction. The decision pathway runs through an allergist, not through a number on a lab report.

When Results Can Be Misleading

• Isolated Ara h 3 positivity: without Ara h 2 elevation, an isolated Ara h 3 result has limited predictive value for true clinical allergy and should not drive decisions on its own.
• Cross-reactivity with other legumes: peanut storage proteins share some structural similarity with other legume proteins; this can occasionally produce positive results in people who tolerate peanuts.
• Recent immunotherapy or biologic treatment: if you are on or recently completed peanut oral immunotherapy, or taking biologic drugs that alter IgE, the result reflects that treatment rather than your baseline allergy status.
• Age and geography: sensitization patterns differ by age and region, so the same number can carry different meaning in a toddler versus an adult, or in different parts of the world.